It is a fresh blow for doctors and patients who hoped a new era of drugs could lessen the deadly toll of prostate cancer, which has been described in the past as a low-profile ‘Cinderella’ disease.Abiraterone joins the list along with Jevtana which was also deemed too expensive just last month. Unfortunately this is what happens when you put too many people on the government system. Healthcare naturally must be rationed. At first it seems it will only be rationed to the very, very sick and the very, very old....but suddenly it must be rationed to anyone that is going to cost any money what-so-ever beyond the scope of normal everyday healthcare.
Trials show men taking abiraterone and a steroid survived for nearly 15 months, while men given steroid treatment and a ‘dummy’ pill lived for 11 months on average.
But some patients live far longer than expected, including Britons who have survived on the drug for more than four years after developing advanced disease. The drug also eased pain for twice as many men in the trials.
Yay for Obamacare........